tiprankstipranks
Trending News
More News >

IntelGenx Foresees Revenue Growth with RIZAFILM Launch

IntelGenx Foresees Revenue Growth with RIZAFILM Launch

IntelGenx Technologies (IGXT) has released an update.

Confident Investing Starts Here:

IntelGenx Technologies Corp. has reported an increase in revenue to $1.04 million for 2023, up from $950,000 the previous year, alongside a reduction in net comprehensive loss from $11.6 million to $10.1 million. The company anticipates a significant revenue boost in 2024 with the Q2 launch of its RIZAFILM product in the United States by Gensco Pharma. Additionally, the company has secured funding through private placements and a Regulation A offering, while also progressing in pharmaceutical and veterinary product development.

For further insights into IGXT stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1